Omandam, Domingo P.
HRN: 24-31-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/05/2024
01/11/2024
IVT
1.5g
Q8
Balanitis;t/c Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes